<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39061051</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>26</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Epidemiological and clinical characteristics of long COVID-19 among Iranians: A community-based study in southern Iran.</ArticleTitle><Pagination><StartPage>2007</StartPage><MedlinePgn>2007</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2007</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-19543-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The study aimed to evaluate the prevalence and pattern of long COVID-19 (LC) symptoms among individuals who had contracted COVID-19, to calculate the incidence of LC, and to provide insights into risk factors associated with developing LC in this population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This population-based cross-sectional survey was conducted in Fars province in 2023. Adult participants with a history of COVID-19 were recruited using a cluster random sampling method, alongside a control group with similar characteristics through the same methodology. Data were collected through in-person interviews using two researcher-developed data collection forms focused on demographic and clinical information.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2010 participants, comprising 1561 (77.7%) and 449 (22.3%) individuals with and without a previous history of COVID-19 were included. Among those with COVID-19 history, the prevalence of experiencing any symptoms was 93.7% (95% CI of 92.3%-94.8%) during the disease acute phase and 36.4% (95% CI of 34.0%-38.8%) after recovery. The incidence of symptoms specifically related to COVID-19, calculated by comparing the symptom rates between participants with and without a history of COVID-19, was found to be 13%. Factors such as older age, previous hospitalization for COVID-19, presence of cardiovascular disease, and use of steroids/chemotherapy were associated with LC symptoms.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our investigation sheds light on long-term aspects of COVID-19, demonstrating a significant prevalence of LC with diverse manifestations. It also underscores the importance of establishing standardized criteria and control groups in research on LC to address challenges related to heterogeneity and potential overestimation of symptoms.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Askarian</LastName><ForeName>Mehrdad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taherifard</LastName><ForeName>Erfan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>MD-MPH Department, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jazzabi</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shayan</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assadian</LastName><ForeName>Ojan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Institute for Skin Integrity and Prevention, Regional Hospital Wiener Neustadt, Wiener Neustadt, Lower Austria, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Skin Integrity and Prevention, University of Huddersfield, Huddersfield, West Yorkshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groot</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hatam</LastName><ForeName>Nahid</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Askarian</LastName><ForeName>Ardalan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Arts &amp; Science, University of Saskatchewan, Saskatoon, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faghihi</LastName><ForeName>Seyed Mohammadebrahim</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taherifard</LastName><ForeName>Ehsan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran. Etaherim123@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Population" UI="C000724774">Iranian people</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094864" MajorTopicYN="N">Middle Eastern People</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Post-Acute, Symptoms</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 Condition</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>28</Day><Hour>14</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>23</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39061051</ArticleId><ArticleId IdType="pmc">PMC11282730</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-19543-1</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-19543-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CDC. COVID-19 Timeline. Last Reviewed: March 15, 2023 [Cited March 6, 2024]; Available from: https://www.cdc.gov/museum/timeline/covid19.html.</Citation></Reference><Reference><Citation>Cascella M, R.M., Aleem A, et al. Features, Evaluation, and Treatment of Coronavirus (COVID-19) [Updated 2023 Aug 18]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/.</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Number of COVID-19 cases reported to WHO (cumulative total). [Cited December 25, 2022]; Available from: https://data.who.int/dashboards/covid19/cases.</Citation></Reference><Reference><Citation>IHME. COVID-19 Results Briefing. January 21, 2022 [Cited December 21, 2022]; Available from: https://www.healthdata.org/sites/default/files/files/1_briefing_Global_5.pdf.</Citation></Reference><Reference><Citation>Marco Cascella, M.R., Abdul Aleem, Scott C. Dulebohn, Raffaela Di Napoli, Features, Evaluation, and Treatment of Coronavirus (COVID-19). Last Update: August 18, 2023, StatPearls Publishing: StatPearls [Internet]. Treasure Island (FL).</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari M, Sayfouri N, Jafari H. Consecutive Waves of COVID-19 in Iran: Various Dimensions and Probable Causes. Disaster Med Public Health Prep. 2022;17:e136. 10.1017/dmp.2022.45</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/dmp.2022.45</ArticleId><ArticleId IdType="pmc">PMC9509792</ArticleId><ArticleId IdType="pubmed">35152937</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirafkan H, et al. Demographics, clinical characteristics, and outcomes in hospitalized patients during six waves of COVID-19 in Northern Iran: a large cohort study. Sci Rep. 2023;13(1):22527. 10.1038/s41598-023-50139-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-50139-8</ArticleId><ArticleId IdType="pmc">PMC10728067</ArticleId><ArticleId IdType="pubmed">38110656</ArticleId></ArticleIdList></Reference><Reference><Citation>Worldometer. Total Coronavirus Cases in Iran. April 13, 2024; Available from: https://www.worldometers.info/coronavirus/country/iran/#google_vignette.</Citation></Reference><Reference><Citation>CDC. Post-COVID Conditions: Overview for Healthcare Providers. Updated Sept. 11, 2023 [Cited December 21, 2022]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Yin, K., et al., Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nature Immunology, 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, et al. Association of SARS-CoV-2 infection and persistence with long COVID. Lancet Respir Med. 2023;11(6):504&#x2013;6. 10.1016/S2213-2600(23)00142-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00142-X</ArticleId><ArticleId IdType="pmc">PMC10171832</ArticleId><ArticleId IdType="pubmed">37178694</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, et al. Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med. 2022;20(1):129. 10.1186/s12967-022-03328-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54(1):1473&#x2013;87. 10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabioni LR, et al. Systemic microvascular dysfunction in COVID-19. Am J Cardiovasc Dis. 2020;10(4):386&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675177</ArticleId><ArticleId IdType="pubmed">33224588</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, et al. Risk Factors Associated With Post&#x2212;COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. 2023;183(6):566&#x2013;80. 10.1001/jamainternmed.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadat Larijani M, et al. Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran. Microb Pathog. 2022;169. 10.1016/j.micpath.2022.105618</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2022.105618</ArticleId><ArticleId IdType="pmc">PMC9176176</ArticleId><ArticleId IdType="pubmed">35690233</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, et al. Long COVID in children and adolescents. World J Pediatr. 2021;17(5):495&#x2013;9. 10.1007/s12519-021-00457-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, et al. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis. 2022;226(9):1593&#x2013;607. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. The Lancet. 2022;400(10350):452&#x2013;61.10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121&#x2013;6. 10.4103/0253-7176.116232</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0253-7176.116232</ArticleId><ArticleId IdType="pmc">PMC3775042</ArticleId><ArticleId IdType="pubmed">24049221</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013;6(1):14&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4017493</ArticleId><ArticleId IdType="pubmed">24834239</ArticleId></ArticleIdList></Reference><Reference><Citation>The population of Iran's provinces at a glance. 29 May, 2022 [Cited February 16, 2024]; Available from: https://amar.org.ir/news/ID/17399/&#x62c;&#x645;&#x639;&#x6cc;&#x62a;-&#x627;&#x633;&#x62a;&#x627;&#x646;-&#x647;&#x627;&#x6cc;-&#x627;&#x6cc;&#x631;&#x627;&#x646;-&#x62f;&#x631;-&#x6cc;&#x6a9;-&#x646;&#x6af;&#x627;&#x647;.</Citation></Reference><Reference><Citation>Leila Doshmangir, M.B., Reza Majdzadeh, And Amirhossein Takian, So Near, So Far: Four Decades of Health Policy Reforms in Iran, Achievements and Challenges. Archives of Iranian Medicine, 22 October, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31679362</ArticleId></ArticleIdList></Reference><Reference><Citation>breistol, U.o. The Wellcome Covid-19 Questionnaire. June 2021; Available from: https://www.bristol.ac.uk/alspac/covid-19/wellcome-covid-19/.</Citation></Reference><Reference><Citation>Hughes SE, et al. Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis. BMJ. 2022;377. 10.1136/bmj-2022-070230</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070230</ArticleId><ArticleId IdType="pmc">PMC9043395</ArticleId><ArticleId IdType="pubmed">35477524</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55. 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A, et al. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci Rep. 2022;12(1):3369. 10.1038/s41598-022-07414-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, N., et al., Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. 2023. 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978404</ArticleId><ArticleId IdType="pubmed">36875356</ArticleId></ArticleIdList></Reference><Reference><Citation>Online Supplementary materials, patient questionnaire. [cited 2023 march 16]; Available from: https://www.dovepress.com/get_supplementary_file.php?f=316186.doC.</Citation></Reference><Reference><Citation>CDC. Symptoms of COVID-19. Updated March 15, 2024 [cited July 5, 2024]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.</Citation></Reference><Reference><Citation>CDC. Defining Adult Overweight &amp; Obesity. Last Reviewed: June 3, 2022 [Cited December 25, 2022]; Available from: https://www.cdc.gov/obesity/basics/adult-defining.html.</Citation></Reference><Reference><Citation>CDC. National Center for Health Statistics. Last reviewed: August 29, 2017 [Cited December 25, 2022]; Available from: https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm#:~:text=Former%20smoker%3A%20An%20adult%20who,at%20the%20time%20of%20interview.</Citation></Reference><Reference><Citation>Ahmad, O.B., C. Boschi Pinto, and A.D. Lopez, Age Standardization of Rates: A New WHO Standard. GPE Discussion Paper Series: No 31, 2001: p. 10&#x2013;12.</Citation></Reference><Reference><Citation>Al-kuraishy HM, et al. Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19. Sci Rep. 2023;13(1):5977. 10.1038/s41598-023-32211-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32211-5</ArticleId><ArticleId IdType="pmc">PMC10092929</ArticleId><ArticleId IdType="pubmed">37045862</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakr AM, El-Sakka AI. Erectile dysfunction among patients and health care providers during COVID-19 pandemic: A systematic review. Int J Impot Res. 2022;34(2):145&#x2013;51. 10.1038/s41443-021-00504-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41443-021-00504-w</ArticleId><ArticleId IdType="pubmed">34992226</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, et al. Prevalence and risk factors of erectile dysfunction in COVID-19 patients: a systematic review and meta-analysis. J Endocrinol Invest. 2023;46(4):795&#x2013;804. 10.1007/s40618-022-01945-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-022-01945-w</ArticleId><ArticleId IdType="pmc">PMC9616422</ArticleId><ArticleId IdType="pubmed">36307637</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell V, et al. Long COVID and older people. Lancet Healthy Longev. 2022;3(12):e849&#x2013;54. 10.1016/S2666-7568(22)00245-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(22)00245-8</ArticleId><ArticleId IdType="pubmed">36480981</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Hamdh, B. and Z. Nazzal, A prospective cohort study assessing the relationship between long-COVID symptom incidence in COVID-19 patients and COVID-19 vaccination. Scientific Reports, 2023. 13(1): p. 4896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10039348</ArticleId><ArticleId IdType="pubmed">36966161</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, et al. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2(1):e000385. 10.1136/bmjmed-2022-000385</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, et al. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41(11):1783&#x2013;90. 10.1016/j.vaccine.2023.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, et al. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis. Brain Behav Immun. 2023;111:211&#x2013;29. 10.1016/j.bbi.2023.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10067136</ArticleId><ArticleId IdType="pubmed">36990297</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia PY, et al. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study. Clin Microbiol Infect. 2022;28(4):612.e1&#x2013;612.e7. 10.1016/j.cmi.2021.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.010</ArticleId><ArticleId IdType="pmc">PMC8608661</ArticleId><ArticleId IdType="pubmed">34826623</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra, P.K., et al., Vaccination boosts protective responses and counters SARS-CoV-2-induced pathogenic memory B cells. medRxiv, 2021.</Citation></Reference><Reference><Citation>Li H, et al. Vaccination reduces viral load and accelerates viral clearance in SARS-CoV-2 Delta variant-infected patients. Ann Med. 2023;55(1):419&#x2013;27. 10.1080/07853890.2023.2166681</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2023.2166681</ArticleId><ArticleId IdType="pmc">PMC9991402</ArticleId><ArticleId IdType="pubmed">36862600</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady, C.B., et al., Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-na&#xef;ve individuals with Long COVID. medRxiv, 2024.</Citation></Reference><Reference><Citation>Edwards F, Hamilton FW. Impact of covid-19 vaccination on long covid. BMJ Medicine. 2023;2(1). 10.1136/bmjmed-2022-000470</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000470</ArticleId><ArticleId IdType="pmc">PMC9978666</ArticleId><ArticleId IdType="pubmed">36936263</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Post COVID-19 condition (Long COVID). 7 December 2022 [Cited December 25, 2022]; Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:~:text=It%20is%20defined%20as%20the,months%20with%20no%20other%20explanation.</Citation></Reference><Reference><Citation>Tracy Beth H, Shamez L, Vinay P. How methodological pitfalls have created widespread misunderstanding about long COVID. BMJ Evid Based Med. 2024;29(3):142&#x2013;6.10.1136/bmjebm-2023-112338</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2023-112338</ArticleId><ArticleId IdType="pmc">PMC11137465</ArticleId><ArticleId IdType="pubmed">37748921</ArticleId></ArticleIdList></Reference><Reference><Citation>Theocharis A, Antonopoulos V, Christodoulou NG. Somatic symptoms associated with mental distress during the COVID-19 pandemic: a systematic review. Australas Psychiatry. 2023;31(2):147&#x2013;56. 10.1177/10398562231156380</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10398562231156380</ArticleId><ArticleId IdType="pmc">PMC9969186</ArticleId><ArticleId IdType="pubmed">36825513</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>